Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion type Assertion NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_head.
- NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion description "[We evaluated the presence of the progesterone receptor (PR), estradiol receptors (ERs), and aromatase in 5 patients with primary pigmented nodular adrenal disease (PPNAD), 15 adrenocortical adenomas (ACAs) and adjacent normal tissues, 12 adrenocortical carcinomas (ACCs), and 3 normal adrenal glands (NA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_provenance.
- NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion evidence source_evidence_literature NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_provenance.
- NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion SIO_000772 18508999 NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_provenance.
- NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion wasDerivedFrom befree-20150227 NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_provenance.
- NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_assertion wasGeneratedBy ECO_0000203 NP617460.RAcbMEmBdd4G_HqTTW9_lzsMNjtvb7zOyxk12ORv89_FY130_provenance.